Skip to main content
. 2022 Jun 1;14(6):1190. doi: 10.3390/pharmaceutics14061190
CPIC Clinical Pharmacogenetics Implementation Consortium
COX-1 Cyclooxygenase 1
COX-2 Cyclooxygenase 2
EM Extensive metabolizer
GI Gastrointestinal
IM Intermediate metabolizer
NM Normal metabolizer
NSAIDs Nonsteroidal anti-inflammatory drugs
PM Poor metabolizer
RM Rapid metabolizer
SNPs Single-nucleotide polymorphisms
SNRIs Serotonin-norepinephrine reuptake inhibitors
SSRIs Selective serotonin reuptake inhibitors
Tmax Time of the maximum plasma concentration
TNF-α Tumor necrosis factor α
TCAs Tricyclic antidepressants
UGTs Uridine 5′-diphospho-glucuronosyltransferase
UGIB Upper gastrointestinal bleeding
UM Ultra-rapid metabolizer
VKOR Vitamin K epoxide reductase
ECG Electrocardiography
Ads Antidepressants